Pfizer Inc
NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024
PFE Articles
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for the coming 12...
Published:
Last Updated:
ThinkstockOn December 7, marijuana became legal in the state of Washington, adding to the list of states that have moved toward legalizing or decriminalizing the drug. Will this be a national trend...
Published:
Last Updated:
Bank of America Merrill Lynch has issued more picks and a macro-investment strategy for 2013, and the message is rather clear: Be selective and position defensively. The firm said that it sees a...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday. Active Network Inc. (NYSE: ACTV) raised to Buy at BofA/ML. Allergan Inc. (NYSE:...
Published:
Last Updated:
ThinkstockMerck & Co. (NYSE: MRK) has joined the dividend hike brigade. We were not sure if the pharmaceutical giant was going to hike its payout, but it has. The company’s board of directors...
Published:
Last Updated:
ThinkstockThe U.S. Securities and Exchange Commission (SEC) today filed criminal charges against a former SAC Capital Advisors hedge-fund manager related to an insider trading scheme that generated...
Published:
courtesy of BP plcBP plc (NYSE: BP) has agreed to pay a total of $4.5 billion dollars and to plead guilty to 11 felony charges in a criminal case brought by the U.S. Department of Justice against the...
Published:
courtesy of BP plcThe U.S. Department of Justice and BP PLC (NYSE: BP) have reportedly reached an agreement on the penalties the company will face related to the blowout of its Macondo well in the...
Published:
courtesy of AppleIn its third annual ranking of the world’s most innovative companies, analysts at Booz & Co. created two lists: one based on dollars spent and the other based on asking those...
Published:
Wikimedia CommonsPfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration approved its drug candidate called XELJANZ. The treatment here is for rheumatoid arthritis and this...
Published:
Last Updated:
Wikimedia CommonsPfizer Inc. (NYSE: PFE) is out with its earnings report for the third quarter, and the drug giant reported that revenues were down 16% to $14.0 billion. Some 12% was due to an...
Published:
Wikimedia CommonsSome companies reportedly have decided to delay their earnings reports as Hurricane Sandy heads for the East Coast and the major U.S. markets are close today, and possibly Tuesday....
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) said today that it will acquire privately held NextWave Pharmaceuticals. NextWave is a specialty pharmaceutical company that focuses on the development and commercialization...
Published:
The coming fiscal cliff represents a huge hurdle for America. Government and private sector forecasters have warned that the expiration of tax cuts, along with hundreds of billions of dollars in...
Published:
Last Updated:
The three major U.S. stock indexes opened lower this morning following a weaker-than-expected report on U.S. personal income and inline personal consumption spending (more coverage here). U.S....
Published:
Last Updated: